Iteria Biopharma is focuses its activity on the development of drugs for the treatment of cancer.
Iteria Biopharma has raised $5.9M in total funding. The most recent round was Seed. The last funding was announced in April 2026.
Iteria Biopharma's investors include Inveready, Xesgalicia.
Iteria Biopharma is headquartered in Touro, Spain.
Iteria Biopharma is focuses its activity on the development of drugs for the treatment of cancer.
Iteria Biopharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Iteria Biopharma — Funding & Investors." VCBacked, April 16, 2026, https://www.vcbacked.co/company/iteria-biopharma. Accessed August 2, 2026.
VCBacked. (2026). Iteria Biopharma — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/iteria-biopharma
{{cite web |title=Iteria Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/iteria-biopharma |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated